In 1974, with his unflinching entrepreneurial spirit and a distinguished PhD in biochemistry, Robert W. Ban founded Quantimetrix.
But his journey didn’t begin there. In 1972, Dr. Ban created a start-up company, Diagnostic Products Corporation (DPC), and developed radioimmunoassay (RIA) diagnostic test kits. The test permitted the measurement of infinitesimally low concentrations of substances in bodily fluids, such as drugs and hormones. The idea was revolutionary and got the attention of many financial investors.
One such investor was Dr. Sigi Ziering. They formed a partnership, and DPC began to flourish.
In 1973, the partnership was dissolved.
Armed with the same drive and determination that gave birth to his DPC start-up, Dr. Ban responded to the needs of the laboratory industry by pioneering a liquid stabilization technology that simplified quality control methods. He believed in the importance of applying the most rigorous standards in development and manufacturing, giving his customers confidence that their test results were accurate and consistent every time.
The Clinical Laboratory Improvement Act (CLIA) of 1988 mandated the use of controls in clinical laboratories. Quantimetrix provided the right products at the right time to a diagnostic community that was eager to satisfy the new requirements. The demand for Quantimetrix products grew and established us as an industry leader.
Dr. Ban’s vision and high standards still drive us today.
Quantimetrix laboratory products are handcrafted – under one roof – in our Redondo Beach, California facility.